Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
9 risultati
Use of modified oligo-.beta.-(1,3)-glucans for treating diseases of the immune system, oligo-.beta.-(1,3)-glucan-(1,3)-mannose, oligo-.beta.-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention relates to the use of modified oligo-.beta.-(1,3)-glucans of formula (I) or (II) below for the preparation of medicaments which are useful in treatments based on the stimulation of the immune system.
The glucans, which are natural products, have long been studied and the
Fructose analogs and their combinations as anti-cancer agents
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention relates to the field of biomedicine, and relates specifically to the use of fructose analogs and the combination of fructose analogs and glucose analogs in the treatment of cancer and organ fibrosis.
BACKGROUND
It is well known that the occurrence and
Lyophilized preparation of cytotoxic dipeptides
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention is directed to lyophilized pharmaceutical preparations comprising cytotoxic dipeptides or pharmaceutically acceptable salts thereof, methods for their preparation, compositions comprising the lyophilized pharmaceutical preparations and their use in the treatment
Lyophilized preparation of cytotoxic dipeptides
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention is directed to lyophilized pharmaceutical preparations comprising cytotoxic dipeptides or pharmaceutically acceptable salts thereof, methods for their preparation, compositions comprising the lyophilized pharmaceutical preparations and their use in the treatment
Vaccine formulations and uses thereof
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to stable formulations of viruses and virus-based vaccines. A difficulty in stabilizing viruses at temperatures below the freezing point of water is preventing the physical disruption of structural and functional components during freezing and thawing.
Vaccine formulations and uses thereof
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to stable formulations of viruses and virus-based vaccines. A difficulty in stabilizing viruses at temperatures below the freezing point of water is preventing the physical disruption of structural and functional components during freezing and thawing.
Ondansetron orally disintegrating tablets
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to non-effervescent, solid dosage forms adapted for oral administration of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carb- azol-4-one (ondansetron) as an anti-emetic active
Hexitols containing free carboxy groups and a process for the preparation thereof
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The invention relates to new hexitols having the formulae (I) and (II), ##STR3## wherein the hexitol skeleton is dulcitol, mannitol or iditol,
X represents halogen, preferably bromine,
R is a saturated or unsaturated C.sub.4-10 alkylcarbonyl group which also contains a free carboxy group,
Lyophilized thioxanthenone antitumor agents
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
This invention relates to lyophilized aqueous parenteral solutions of antitumor agents. More particularly, this invention relates to lyophilized aqueous thioxanthenone antitumor agents.
Reported Developments
Many conventional drug substances and proteins destined for
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
